Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury

Journal of the American Society of Nephrology

Volumn 23, Issue 2, 2012, Pages 266-280

  Park, Sang Won ^a   Kim, Mihwa ^a   Brown, Kevin M ^a   D'Agati, Vivette D ^a   Lee, H Thomas ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; CAY 10444; CYCLOHEXIMIDE; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN KINASE; RHO KINASE; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; SPHINGOSINE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; W 146;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

EID: 84863116009     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011050503     Document Type: Article

References (60)

1. Faubel S: Acute kidney injury and multiple organ dysfunction syndrome. Minerva Urol Nefrol 61: 171-188, 2009
2. Jones DR, Lee HT: Perioperative renal protection. Best Pract Res Clin Anaesthesiol 22: 193-208, 2008 (Pubitemid 351405119)
3. Aronson S, Blumenthal R: Perioperative renal dysfunction and cardiovascular anesthesia: concerns and controversies. J Cardiothorac Vasc Anesth 12: 567-586, 1998 (Pubitemid 28473821)
4. Star RA: Treatment of acute renal failure. Kidney Int 54: 1817-1831, 1998
5. Jo SK, Rosner MH, Okusa MD: Pharmacologic treatment of acute kidney injury: Why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol 2: 356-365, 2007
6. Jones DR, Lee HT: Protecting the kidney during critical illness. Curr Opin Anaesthesiol 20: 106-112, 2007 (Pubitemid 46594844)
7. Li X, Hassoun HT, Santora R, Rabb H: Organ crosstalk: The role of the kidney. Curr Opin Crit Care 15: 481-487, 2009
8. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S: Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758: 2016-2026, 2006 (Pubitemid 44879368)
9. Jo SK, Bajwa A, Awad AS, Lynch KR, Okusa MD: Sphingosine-1-phosphate receptors: Biology and therapeutic potential in kidney disease. Kidney Int 73: 1220-1230, 2008 (Pubitemid 351693151)
10. Singleton PA, Chatchavalvanich S, Fu P, Xing J, Birukova AA, Fortune JA, Klibanov AM, Garcia JG, Birukov KG: Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res 104: 978-986, 2009
11. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schäfers M, Herrgott I, Mersmann J, Larmann J, Hermann S, Stypmann J, Schober O, Hildebrand R, Schulz R, Heusch G, Haude M, von Wnuck Lipinski K, Herzog C, Schmitz M, Erbel R, Chun J, Levkau B: High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114: 1403-1409, 2006 (Pubitemid 44454560)
12. Wang S, Zhang Z, Lin X, Xu DS, Feng Y, Ding K: A polysaccharide, MDG-1, induces S1P1 and bFGF expression and augments survival and angiogenesis in the ischemic heart. Glycobiology 20: 473-484, 2010
13. Lien YH, Yong KC, Cho C, Igarashi S, Lai LW: S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int 69: 1601-1608, 2006
14. Awad AS, Ye H, Huang L, Li L, Foss FW Jr, Macdonald TL, Lynch KR, Okusa MD: Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney. Am J Physiol Renal Physiol 290: F1516-F1524, 2006 (Pubitemid 43830779)
15. Park SW, Kim M, Chen SW, Brown KM, D'Agati VD, Lee HT: Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation. Lab Invest 90: 1209-1224, 2010
16. Skoura A, Hla T: Regulation of vascular physiology and pathology by the S1P2 receptor subtype. Cardiovasc Res 82: 221-228, 2009
17. Inoki I, Takuwa N, Sugimoto N, Yoshioka K, Takata S, Kaneko S, Takuwa Y: Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor. Biochem Biophys Res Commun 346: 293-300, 2006 (Pubitemid 43865997)
18. Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH: International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev 62: 579-587, 2010
19. Jablonski P, Howden BO, Rae DA, Birrell CS, Marshall VC, Tange J: An experimental model for assessment of renal recovery from warm ischemia. Transplantation 35: 198-204, 1983 (Pubitemid 13113785)
20. Ikeda H, Satoh H, Yanase M, Inoue Y, Tomiya T, Arai M, Tejima K, Nagashima K, Maekawa H, Yahagi N, Yatomi Y, Sakurada S, Takuwa Y, Ogata I, Kimura S, Fujiwara K: Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. Gastroenterology 124: 459-469, 2003 (Pubitemid 36169262)
21. Teraishi K, Kurata H, Nakajima A, Takaoka M, Matsumura Y: Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion- induced acute renal failure in rats. Eur J Pharmacol 505: 205-211, 2004 (Pubitemid 39535693)
22. Goparaju SK, Jolly PS, Watterson KR, Bektas M, Alvarez S, Sarkar S, Mel L, Ishii I, Chun J, Milstien S, Spiegel S: The S1P2 receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol Cell Biol 25: 4237-4249, 2005 (Pubitemid 40617669)
23. Kim M, Kim M, Park SW, Pitson SM, Lee HT: Isoflurane protects human kidney proximal tubule cells against necrosis via sphingosine kinase and sphingosine-1-phosphate generation. Am J Nephrol 31: 353-362, 2010
24. Kim M, Kim M, Kim N, D'Agati VD, Emala CW Sr, Lee HT: Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways. Am J Physiol Renal Physiol 293: F1827-F1835, 2007 (Pubitemid 350179608)
25. Vessey DA, Kelley M, Li L, Huang Y, Zhou HZ, Zhu BQ, Karliner JS: Role of sphingosine kinase activity in protection of heart against ischemia reperfusion injury. Med Sci Monit 12: BR318-BR324, 2006 (Pubitemid 44556077)
26. Saba JD, Hla T: Point-counterpoint of sphingosine 1-phosphate metabolism. Circ Res 94: 724-734, 2004 (Pubitemid 38451733)
27. Schwalm S, Döll F, Römer I, Bubnova S, Pfeilschifter J, Huwiler A: Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells. Biochem Biophys Res Commun 368: 1020-1025, 2008
28. Chae SS, Proia RL, Hla T: Constitutive expression of the S1P1 receptor in adult tissues. Prostaglandins Other Lipid Mediat 73: 141-150, 2004 (Pubitemid 38446477)
29. Allende ML, Dreier JL, Mandala S, Proia RL: Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem279: 15396-15401, 2004 (Pubitemid 38618938)
30. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG: Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355-360, 2004 (Pubitemid 38133663)
31. Lai LW, Yong KC, Igarashi S, Lien YH. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int 71: 1223-1231, 2007 (Pubitemid 46884247)
32. Bajwa A, Jo SK, Ye H, Huang L, Dondeti KR, Rosin DL, Haase VH, Macdonald TL, Lynch KR, Okusa MD: Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury. J Am Soc Nephrol 21: 955-965, 2010
33. Rosen H: High throughput screening for S1P receptor agonists and antagonists, S1P2 agonist. The Scripps Molecular Screening Center Probe Report, 2011. Available at: http://mli.nih.gov/mli/?dl-id=720. Accessed December 7, 2007
34. Kono M, Belyantseva IA, Skoura A, Frolenkov GI, Starost MF, Dreier JL, Lidington D, Bolz SS, Friedman TB, Hla T, Proia RL: Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 282: 10690-10696, 2007 (Pubitemid 47093459)
35. Skoura A, Michaud J, Im DS, Thangada S, Xiong Y, Smith JD, Hla T: Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler Thromb Vasc Biol 31: 81-85, 2011
36. Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T: Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest 117: 2506-2516, 2007 (Pubitemid 47494352)
37. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T: Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol 27: 1312-1318, 2007 (Pubitemid 46809419)
38. Van Brocklyn JR, Tu Z, Edsall LC, Schmidt RR, Spiegel S: Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J Biol Chem 274: 4626-4632, 1999
39. Jolly PS, Bektas M, Olivera A, Gonzalez-Espinosa C, Proia RL, Rivera J, Milstien S, Spiegel S: Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis. J Exp Med 199: 959-970, 2004 (Pubitemid 38481087)
40. Wang F, Okamoto Y, Inoki I, Yoshioka K, Du W, Qi X, Takuwa N, Gonda K, Yamamoto Y, Ohkawa R, Nishiuchi T, Sugimoto N, Yatomi Y, Mitsumori K, Asano M, Kinoshita M, Takuwa Y: Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J Clin Invest 120: 3979-3995, 2010
41. Means CK, Xiao CY, Li Z, Zhang T, Omens JH, Ishii I, Chun J, Brown JH. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 292: H2944-H2951, 2007 (Pubitemid 47084545)
42. Serriere-Lanneau V, Teixeira-Clerc F, Li L, Schippers M, de Wries W, Julien B, Tran-Van-Nhieu J, Manin S, Poelstra K, Chun J, Carpentier S, Levade T, Mallat A, Lotersztajn S. The sphingosine 1-phosphate receptor S1P2 triggers hepatic wound healing. FASEB J 21: 2005-2013, 2007 (Pubitemid 47026436)
43. Maceyka M, Payne SG, Milstien S, Spiegel S: Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 1585: 193-201, 2002 (Pubitemid 36096858)
44. Wadgaonkar R, Patel V, Grinkina N, Romano C, Liu J, Zhao Y, Sammani S, Garcia JG, Natarajan V: Differential regulation of sphingosine kinases 1 and 2 in lung injury. Am J Physiol Lung Cell Mol Physiol 296: L603-L613, 2009
45. Young N, Van Brocklyn JR: Signal transduction of sphingosine-1-phosphate G protein-coupled receptors. ScientificWorldJournal 6: 946-966, 2006 (Pubitemid 44252720)
46. Mooberry SL: Mechanism of action of 2-methoxyestradiol: new developments. Drug Resist Updat 6: 355-361, 2003
47. Schödel J, Klanke B, Weidemann A, Buchholz B, Bernhardt W, Bertog M, Amann K, Korbmacher C, Wiesener M, Warnecke C, Kurtz A, Eckardt KU, Willam C: HIF-prolyl hydroxylases in the rat kidney: Physiologic expression patterns and regulation in acute kidney injury. Am J Pathol 174: 1663-1674, 2009
48. Rosenberger C, Rosen S, Shina A, Frei U, Eckardt KU, Flippin LA, Arend M, Klaus SJ, Heyman SN: Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney. Nephrol Dial Transplant 23: 3472-3478, 2008
49. Olivera A, Mizugishi K, Tikhonova A, Ciaccia L, Odom S, Proia RL, Rivera J: The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis. Immunity 26: 287-297, 2007 (Pubitemid 46413904)
50. Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, van Echten-Deckert G, Hajdu R, Rosenbach M, Keohane CA, Mandala S, Spiegel S, Proia RL: Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem 279: 52487-52492, 2004 (Pubitemid 39656625)
51. Park SW, Chen SW, Kim M, Brown KM, Kolls JK, D'Agati VD, Lee HT: Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Lab Invest 91: 63-84, 2011
52. Kim M, Park SW, Kim M, Chen SW, Gerthoffer WT, D'Agati VD, Lee HT. Selective renal over-expression of human heat shock protein 27 reduces renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol 299: F347-358, 2010
53. Puneet P, Yap CT, Wong L, Lam Y, Koh DR, Moochhala S, Pfeilschifter J, Huwiler A, Melendez AJ: SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science 328: 1290-1294, 2010
54. Wong L, Tan SS, Lam Y, Melendez AJ: Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases. J Med Chem 52: 3618-3626, 2009
55. Slot C: Plasma creatinine determination. A new and specific Jaffe reaction method. Scand J Clin Lab Invest 17: 381-387, 1965
56. Park SW, Kim M, Chen SW, D'Agati VD, Lee HT: Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice. Shock 33: 31-42, 2010
57. Lee HT, Kim M, Jan M, Emala CW: Anti-inflammatory and antinecrotic effects of the volatile anesthetic sevoflurane in kidney proximal tubule cells. Am J Physiol Renal Physiol 291: F67-F78, 2006 (Pubitemid 43945937)
58. Lee HT, Emala CW: Adenosine attenuates oxidant injury in human kidney proximal tubular cells via A1 and A2a adenosine receptors. Am J Physiol Renal Physiol 282: F844-F852, 2002 (Pubitemid 34654490)
59. Lee HT, Kim M, Jan M, Penn RB, Emala CW: Renal tubule necrosis and apoptosismodulation by A1 adenosine receptor expression. Kidney Int 71: 1249-1261, 2007 (Pubitemid 46884252)
60. Vinay P, Gougoux A, Lemieux G: Isolation of a pure suspension of rat proximal tubules. Am J Physiol 241: F403-F411, 1981